These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 16802535)
1. [Therapy of acute decompensated heart failure with levosimendan]. Müller K; Peters A; Zeus T; Hennersdorf M; Strauer BE Med Klin (Munich); 2006 Mar; 101 Suppl 1():119-22. PubMed ID: 16802535 [TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096 [TBL] [Abstract][Full Text] [Related]
3. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Delle Karth G; Buberl A; Geppert A; Neunteufl T; Huelsmann M; Kopp C; Nikfardjam M; Berger R; Heinz G Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. Nieminen MS; Akkila J; Hasenfuss G; Kleber FX; Lehtonen LA; Mitrovic V; Nyquist O; Remme WJ J Am Coll Cardiol; 2000 Nov; 36(6):1903-12. PubMed ID: 11092663 [TBL] [Abstract][Full Text] [Related]
7. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure]. Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ J Clin Pharmacol; 2002 Jan; 42(1):43-51. PubMed ID: 11808823 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure]. Wang L; Cui L; Wei JP; Li GP; Qi GX; Hao YM; Wang WZ; Li HM; Liu J; Jiang DJ; Zhang YD Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):527-30. PubMed ID: 21033135 [TBL] [Abstract][Full Text] [Related]
13. ST-segment elevation during levosimendan infusion. Barillà F; Giordano F; Jacomelli I; Pellicano M; Dominici T J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):454-6. PubMed ID: 22673026 [TBL] [Abstract][Full Text] [Related]
14. Levosimendan: a review of its use in the management of acute decompensated heart failure. Innes CA; Wagstaff AJ Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085 [TBL] [Abstract][Full Text] [Related]
15. Levosimendan: a retrospective single-center case series. Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721 [TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of levosimendan in patients with predominant right heart failure. Poelzl G; Zwick RH; Grander W; Metzler B; Jonetzko P; Frick M; Ulmer H; Pachinger O; Roithinger FX Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157 [TBL] [Abstract][Full Text] [Related]
17. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355 [TBL] [Abstract][Full Text] [Related]
18. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930 [TBL] [Abstract][Full Text] [Related]
19. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study]. Paksoy F; Ulaş T; Tursun I; Dal MS; Oztekin E; Borlu F Anadolu Kardiyol Derg; 2012 Feb; 12(1):16-22. PubMed ID: 22214738 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]